ALS (Amyotrophic Lateral Sclerosis)

Clinical Outcome Assessment for AT & BCI

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Invasive Home Ventilation in Denmark

Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

Intermediate-size Patient Population Expanded Access Protocol

Evaluation of a Structurally Suitable Neck Exoskeleton in Patients With Amyotrophic Lateral Sclerosis

Characterization of Platelet Molecular Profiles in ALS for the Identification of Specific Diagnostic Biomarkers - A Pilot Study

Virtual Reality for Anxiety Management in Persons With Amyotrophic Lateral Sclerosis

A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

Healey ALS MyMatch Common Screening Protocol

Kamlanoflast In Amyotrophic Lateral Sclerosis

Tofersen in Non-SOD1 ALS

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis

This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling

Tongue-strengthening Exercises in People With ALS.